Dose-dependency of MBP-induced demyelination in the guinea pig.
The pathology of experimental allergic encephalomyelitis (EAE) induced by bovine myelin basic protein (MBP) has been examined in the guinea pig with a series of doses ranging from 37.5 micrograms to 600 micrograms. This was to investigate whether the previously demonstrated lack of demyelinative effect by MBP was dose-related. At all doses tested, MBP induced clinical disease. Inflammation was the major feature of lesions in all animals. However, no demyelination was seen when 75 micrograms MBP or less was given. At higher doses (150 micrograms upwards), MBP always induced intense inflammation but demyelination was encountered inconsistently. These observations support the contention that in addition to an immune response to MBP, other factors contribute to autoimmune demyelination.
Moore
G R
GR
Traugott
U
U
Stone
S H
SH
Raine
C S
CS
D000818:Animals; D001323:Autoantibodies / Q000032:analysis; D004306:Dose-Response Relationship, Immunologic; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D005260:Female; D005699:Galactosylceramides / Q000276:immunology; D006168:Guinea Pigs; D007249:Inflammation; D004676:Myelin Basic Protein / Q000008:administration & dosage* / Q000276:immunology; D009186:Myelin Sheath / Q000473:pathology
D001323:Autoantibodies; D005699:Galactosylceramides; D004676:Myelin Basic Protein; C002454:galactocerebroside